Garfield Alastair

Chief Scientific Officer at RYTM

Sold, on record
$998k
Dollars the filings state
Form 4 sales
2
Latest Aug 13, 2026
Form 144 notices
1
Proposed sales
Quarters with a sale
2 of the last 8
2 days with a sale in that time
Companies
1
Filed as an executive or holder

Companies

  • RYTMRHYTHM PHARMACEUTICALS, INC.Chief Scientific Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. Aug 13, 2026Routine

    RYTM

    Sold 77.2% of their holdings

    $913k7,763 shares at $117.57

    Filed Aug 17, 2026Form 4

  2. Aug 13, 2026Notice

    RYTM

    Filed a notice to sell 7,763 shares

    $913k7,763 shares

    Filed Aug 13, 2026Form 144

  3. Jul 2, 2025Routine

    RYTM

    Sold 29.7% of their holdings

    $85k1,319 shares at $64.81

    Filed Jul 3, 2025Form 4

3 of 3

Every transaction

Every transaction on a Form 4 or Form 5 by Garfield Alastair
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Aug 13, 2026Aug 17, 2026RYTMChief Scientific OfficerSold7,763$117.57$913k2,295SEC
Jul 1, 2026Jul 2, 2026RYTMChief Scientific OfficerExercised or settledRestricted Stock Units4,4458,888SEC
Jul 1, 2026Jul 2, 2026RYTMChief Scientific OfficerExercised options4,44512,208SEC
Jul 1, 2026Jul 2, 2026RYTMChief Scientific OfficerWithheld for tax2,150$110.41$237k10,058SEC
Feb 11, 2026Feb 13, 2026RYTMChief Scientific OfficerAwardedRestricted Stock Units41,65025,000SEC
Feb 1, 2026Feb 3, 2026RYTMChief Scientific OfficerExercised or settledRestricted Stock Units6,66319,987SEC
Feb 1, 2026Feb 3, 2026RYTMChief Scientific OfficerExercised options6,6639,789SEC
Feb 1, 2026Feb 3, 2026RYTMChief Scientific OfficerWithheld for tax2,026$108.99$221k7,763SEC
Jul 2, 2025Jul 3, 2025RYTMChief Scientific OfficerSold1,319$64.81$85k3,126SEC
Jul 1, 2025Jul 3, 2025RYTMChief Scientific OfficerExercised or settledRestricted Stock Units4,44513,333SEC
Jul 1, 2025Jul 3, 2025RYTMChief Scientific OfficerExercised options4,4454,445SEC
Feb 14, 2025Feb 19, 2025RYTMChief Scientific OfficerAwardedRestricted Stock Units66,65040,000SEC
Jul 8, 2024Jul 10, 2024RYTMChief Scientific OfficerAwardedStock Option (right to buy)71,11117,778SEC

Sales and notices (3)

Form 144 notices and Form 4 sales by Garfield Alastair
Source
Aug 13, 2026Aug 17, 2026RYTMChief Scientific OfficerForm 4 sale7,763$913k77.2%RoutineSEC
Aug 13, 2026Aug 13, 2026RYTMChief Scientific OfficerForm 144 notice7,763$913kNoticeSEC
Jul 2, 2025Jul 3, 2025RYTMChief Scientific OfficerForm 4 sale1,319$85k29.7%RoutineSEC